Related Experiment Video
Updated: Jan 7, 2026

11:21
Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Published on: July 27, 2018
8.6K
Understanding and guiding technology use in dementia: a pan-European mapping and consensus study.
Canaan Tsabary1, Duygu Sezgin2, Anthea Innes3,4
1School of Psychology, Dublin City University, Dublin, Ireland.
Frontiers in Dementia
|January 2, 2026
Summary
Assistive technologies (AT) adoption by people with dementia increased during the pandemic, revealing digital literacy and support gaps. This study provides 18 recommendations for better AT development and use in dementia care.
Area of Science:
- Gerontology
- Health Informatics
- Assistive Technology Research
Background:
- Dementia prevalence is rising globally, increasing the need for supportive technologies.
- Assistive technologies (AT) can enhance independence and quality of life for individuals with dementia.
- The COVID-19 pandemic accelerated AT adoption among people with dementia, highlighting existing challenges.
Purpose of the Study:
- To map digital technology research for people with dementia during the pandemic.
- To synthesize evidence-based recommendations for AT development and support in dementia care.
- To establish a framework for improving AT efficacy and adoption.
Main Methods:
- A pan-European study involving a mapping exercise of 28 research initiatives.
- Utilized the Delphi method with experts by experience and researchers.
- Incorporated findings from a scoping review and the mapping exercise.
Main Results:
- Video-conferencing platforms were the most common digital technologies used.
- 17 projects were adapted to include digital technologies due to the pandemic.
- 18 evidence-based recommendations were developed through expert consensus.
Conclusions:
- Involving people with dementia in technology design is crucial.
- Ensuring equitable access, training, and support are key for successful AT adoption.
- The recommendations provide a framework to improve AT efficacy and global dementia care.
Keywords:
COVID-19Delphi methodassistive technologydementiaexpert consensusmapping exercisepublic involvementMore Related Videos
Related Concept Videos
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744

